Добавлены профессиональными переводчиками и компаниями и на основе веб-страниц и открытых баз переводов.
felszívódás a ropinirol biohasznosulása kb.
the bioavailability of ropinirole is about 50% (36% to 57%), with cmax reached on average 1.5 hours after the dose.
parkinson- kórban a ropinirol- kezelés aluszékonysággal
in parkinson’ s disease, ropinirole is associated with somnolence and has been associated uncommonly (> 1/ 1,000, < 1/ 100) with excessive daytime somnolence and sudden sleep onset episodes, however, in restless legs syndrome, this phenomenon is very rare (< 1/ 10,000).
a ropinirol óvatosan adható mérsékelt májkárosodásban szenved betegeknek.
24/94 ropinirole should be administered with caution to patients with moderate hepatic impairment.
a ropinirol plazmakoncentrációjának növekedését észlelték hormonpótló terápia (hrt) mellett.
increased plasma concentrations of ropinirole have been observed in patients treated with hormone replacement therapy.
38, 4% ci95% 28, 1%; 48, 6%, ropinirol/ rotigotin különbség:
all differences between the active treatments and placebo were statistically significant.
tüneteinek a kezelésére) , ropinirol (parkinson-kór kezelésére) és tizanidin (izomgörcsök kezelésére) .
symptoms of alzheimer´s disease) , ropinirol (used to treat parkinson disease) and tizanidine (used to treat muscle spasms) .